| Mrs Sonia Andree Petite, RN | |
|
3415 Valley Road, Liberty Corner, NJ 07938-0825 | |
| (908) 647-0800 | |
| Not Available |
| Full Name | Mrs Sonia Andree Petite |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent |
| Location | 3415 Valley Road, Liberty Corner, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578641841 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sonia Andree Petite, RN 3415 Valley Road, P.o. Box 825, Liberty Corner, NJ 07938-0825 Ph: (908) 647-0800 | Mrs Sonia Andree Petite, RN 3415 Valley Road, Liberty Corner, NJ 07938-0825 Ph: (908) 647-0800 |
News Archive
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.
This protection is provided by a human protein, Elafin, which is artificially introduced into dairy produce bacteria (Lactococcus lactis and Lactobacillus casei). In time, this discovery could be useful for individuals suffering from chronic inflammatory diseases such as Crohn's disease or ulcerative colitis.
Baylor College of Medicine and Baylor Scott & White Health have entered into an agreement to expand biomedical research in North and Central Texas.
› Verified 7 days ago